Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 3
2010 1
2011 7
2012 1
2013 3
2014 4
2015 2
2016 5
2017 6
2018 7
2019 5
2020 6
2021 14
2022 4
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
Patiño-García A, Guruceaga E, Andueza MP, Ocón M, Fodop Sokoudjou JJ, de Villalonga Zornoza N, Alkorta-Aranburu G, Uria IT, Gurpide A, Camps C, Jantus-Lewintre E, Navamuel-Andueza M, Sanmamed MF, Melero I, Elgendy M, Fusco JP, Zulueta JJ, de-Torres JP, Bastarrika G, Seijo L, Pio R, Montuenga LM, Hernáez M, Ochoa I, Perez-Gracia JL. Patiño-García A, et al. Among authors: jantus lewintre e. EBioMedicine. 2024 Apr;102:105048. doi: 10.1016/j.ebiom.2024.105048. Epub 2024 Mar 13. EBioMedicine. 2024. PMID: 38484556 Free PMC article.
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Macaya I, Roman M, Welch C, Entrialgo-Cadierno R, Salmon M, Santos A, Feliu I, Kovalski J, Lopez I, Rodriguez-Remirez M, Palomino-Echeverria S, Lonfgren SM, Ferrero M, Calabuig S, Ludwig IA, Lara-Astiaso D, Jantus-Lewintre E, Guruceaga E, Narayanan S, Ponz-Sarvise M, Pineda-Lucena A, Lecanda F, Ruggero D, Khatri P, Santamaria E, Fernandez-Irigoyen J, Ferrer I, Paz-Ares L, Drosten M, Barbacid M, Gil-Bazo I, Vicent S. Macaya I, et al. Among authors: jantus lewintre e. Nat Commun. 2023 Oct 10;14(1):6332. doi: 10.1038/s41467-023-41828-z. Nat Commun. 2023. PMID: 37816716 Free PMC article.
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma.
Torres-Martínez S, Calabuig-Fariñas S, Moreno-Manuel A, Bertolini G, Herreros-Pomares A, Escorihuela E, Duréndez-Saéz E, Guijarro R, Blasco A, Roz L, Camps C, Jantus-Lewintre E. Torres-Martínez S, et al. Among authors: jantus lewintre e. Mol Oncol. 2024 Jan;18(1):190-215. doi: 10.1002/1878-0261.13505. Epub 2023 Nov 1. Mol Oncol. 2024. PMID: 37567864 Free PMC article.
Biological insights in non-small cell lung cancer.
Rosell R, Jain A, Codony-Servat J, Jantus-Lewintre E, Morrison B, Ginesta JB, González-Cao M. Rosell R, et al. Among authors: jantus lewintre e. Cancer Biol Med. 2023 Jun 28;20(7):500-18. doi: 10.20892/j.issn.2095-3941.2023.0108. Cancer Biol Med. 2023. PMID: 37381723 Free PMC article. Review.
Clinical and technical insights of tumour mutational burden in non-small cell lung cancer.
Meri-Abad M, Moreno-Manuel A, García SG, Calabuig-Fariñas S, Pérez RS, Herrero CC, Jantus-Lewintre E. Meri-Abad M, et al. Among authors: jantus lewintre e. Crit Rev Oncol Hematol. 2023 Feb;182:103891. doi: 10.1016/j.critrevonc.2022.103891. Epub 2022 Dec 21. Crit Rev Oncol Hematol. 2023. PMID: 36565893 Free article. Review.
70 results